 Medexus Pharmaceuticals Inc. OTCQX:MEDXF Q2 2023 Earnings Conference Call November 9, 2022 8:00 AM ET Company Participants Victoria Rutherford - Investor Relations, Adelaide Capital Ken dEntremont - Chief Executive Officer Marcel Konrad - Chief Financial Officer Conference Call Participants Andre Uddin - Research Capital Justin Keywood - Stifel Rahul Sarugaser - Raymond James Scott Henry - ROTH Capital Partners Prasath Pandurangan - Bloom Burton Operator Good morning, ladies and gentlemen and welcome to the Medexus Pharmaceuticals Second Quarter 2023 Earnings Call. Operator Instructions It is now my pleasure to turn the floor over to your host, Ms. 